{"title":"Decoding a Doctor’s Prescription: A Study","authors":"Cedric Thomas Silveira","doi":"10.1177/22786821231161247","DOIUrl":null,"url":null,"abstract":"Doctors today have very little time to listen to a medical representative. They have become patient-centric and feel that listening to a medical representative is a waste of their time. Wishing to learn what could make a doctor prescribe a drug when visited by the medical representative, I drew up a questionnaire consisting of product-centric variables and non-product-based variables. The questionnaire had six variables, which had to be ranked from 1 to 6, with 1 being the most important and 6 being the least important. The variables were easy availability, economical drugs, company name, sponsorships, medical representative’s dedication, and samples among the non-product-based variables and safety, efficacy, tried and tested, less drug interactions, good reviews of the drug, and less adverse effects among the product-based factors. A total of 100 doctors were interviewed. A personal interview was conducted wherein the questionnaire was direct and structured. The results were such that in Thurstone Case V Scaling, economical drugs were considered as the most effective way to get doctors to prescribe, followed by easy availability, company name, medical rep dedication, samples, and sponsorships among the non-product-centric factors, whereas in the product-centric factors, it included efficacy, followed by time tested, less adverse effects, safety, less drug interactions, and good drug reviews. In Karl Pearson’s coefficient of correlation, it was found that a high, positive correlation existed between economical drugs and efficacious drugs and a medium, positive correlation existed between economical drugs and safe drugs. Similarly, a medium–high correlation existed between company name and time-tested drugs.","PeriodicalId":230921,"journal":{"name":"Jindal Journal of Business Research","volume":"70 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jindal Journal of Business Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/22786821231161247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Doctors today have very little time to listen to a medical representative. They have become patient-centric and feel that listening to a medical representative is a waste of their time. Wishing to learn what could make a doctor prescribe a drug when visited by the medical representative, I drew up a questionnaire consisting of product-centric variables and non-product-based variables. The questionnaire had six variables, which had to be ranked from 1 to 6, with 1 being the most important and 6 being the least important. The variables were easy availability, economical drugs, company name, sponsorships, medical representative’s dedication, and samples among the non-product-based variables and safety, efficacy, tried and tested, less drug interactions, good reviews of the drug, and less adverse effects among the product-based factors. A total of 100 doctors were interviewed. A personal interview was conducted wherein the questionnaire was direct and structured. The results were such that in Thurstone Case V Scaling, economical drugs were considered as the most effective way to get doctors to prescribe, followed by easy availability, company name, medical rep dedication, samples, and sponsorships among the non-product-centric factors, whereas in the product-centric factors, it included efficacy, followed by time tested, less adverse effects, safety, less drug interactions, and good drug reviews. In Karl Pearson’s coefficient of correlation, it was found that a high, positive correlation existed between economical drugs and efficacious drugs and a medium, positive correlation existed between economical drugs and safe drugs. Similarly, a medium–high correlation existed between company name and time-tested drugs.